Merck KGaA Company Profile (FRA:MRK)

Analyst Ratings

Consensus Ratings for Merck KGaA (FRA:MRK) (?)
Ratings Breakdown: 2 Sell Rating(s), 8 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Hold (Score: 2.45)
Consensus Price Target: €96.81

Analysts' Ratings History for Merck KGaA (FRA:MRK)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Deutsche Bank AGSet Price TargetBuy€110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016Citigroup Inc.Set Price TargetBuy€115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016Bankhaus LampeSet Price TargetBuy€102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2016Commerzbank AGSet Price TargetBuy€101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2016Independent Research GmbHSet Price TargetNeutral€99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2016Berenberg BankSet Price TargetBuy€101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2016Equinet Institutional ServicesSet Price TargetBuy€85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Baader BankSet Price TargetNeutral€97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Morgan StanleySet Price TargetSell€92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016BNP ParibasSet Price TargetBuy€108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Nord/LBSet Price TargetBuy€102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Warburg ResearchSet Price TargetBuy€103.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Barclays PLCSet Price TargetNeutral€87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Goldman Sachs Group Inc.Set Price TargetNeutral€91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016Bank of America Corp.Set Price TargetBuy€98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016HSBCSet Price TargetNeutral€88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Societe GeneraleSet Price TargetNeutral€82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Credit Suisse Group AGSet Price TargetBuy€104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015S&P Equity ResearchSet Price TargetNeutral€104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Kepler Capital MarketsSet Price TargetSell€75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2014 forward)

Earnings

Earnings History for Merck KGaA (FRA:MRK)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Merck KGaA (FRA:MRK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Merck KGaA (FRA:MRK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Merck KGaA (FRA:MRK)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Merck KGaA (FRA:MRK)
DateHeadline
07/29/16 05:25 PMAfter PhIII disaster, NewLink Genetics plots reorganization
07/27/16 08:12 AMMerck’s 2Q16 Estimates: Expect Operational Growth in Revenues -
07/27/16 05:47 AMWhat to Expect from Merck’s 2Q16 Earnings -
07/26/16 08:31 AMGermany stocks higher at close of trade; DAX up 0.50%
07/25/16 09:47 AMMerck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review -
07/24/16 04:50 PMA report released earlier today by Independent Research GmbH about (ETR:MRK) Merck ups the target price to 99EUR
07/12/16 04:30 PMBig Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere -
07/12/16 01:59 PMMerck (MRK) Stock Gaining, Cutting Research Jobs -
07/12/16 01:52 PM[$$] Merck to Cut Research Jobs at Three East-Coast Sites -
06/30/16 09:32 AMMerck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients -
06/28/16 01:28 PMGilead Sciences: Dominating -
06/23/16 05:43 PMGermany stocks higher at close of trade; DAX up 1.85%
06/15/16 05:15 PMGermany stocks higher at close of trade; DAX up 0.92%
06/14/16 05:01 PMFDA’s Pazdur chides biopharma for falling into an I/O rut
06/10/16 05:30 PMRegulator says too many drugmakers chasing same cancer strategy
06/10/16 05:30 PMToo Many Drug Companies Chasing Same Cancer Strategy: FDA
06/10/16 05:30 PMGermany stocks lower at close of trade; DAX down 2.52%
06/01/16 05:43 PMMerck KGaA (MRK) Given a €99.00 Price Target at Berenberg Bank - "We are excited to share this declarement with Canadian cancer patients during Melanoma Awareness Month", says Chirfi Guindo, President and Managing Director Merck Canada Inc. (NYSE:MRK) has risen 8.59% since October 22, 2015 and is uptrending. According ...
06/01/16 05:43 PMMerck KGaA (MRK) Given a €99.00 Price Target by Berenberg Bank Analysts - Finally, Barclays set a €88.00 ($97.78) target price on shares of Merck KGaA and gave the stock a "neutral" rating in a research report on Tuesday, February 9th. The company's revenue was down -1.2 % compared to the same quarter last year.During the same ...
05/27/16 01:44 PMCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases - Motley Fool - Motley FoolCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract ReleasesMotley FoolThe first is Merck's (NYSE:MRK) Keytruda, which is approved to treat first- and second-line advanced melanoma, as well as second-line advanced non-small-cell lung cancer (NSCLC) in patients with high levels of PD-L1 expression. ... It will be ...and more »
05/02/16 07:10 AMMerck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry - [at noodls] - Press Release Template News Release Your Contact Karen Tiano +1 978 495 0093 May 2, 2016 Flexible factory concept allows accelerated drug development and delivery to market ... This is an abstract of the ...
01/28/16 05:11 AMMerck Accelerator goes global with launch in Africa - [at noodls] - Press Release Template News Release Your Contact Annika Zille +49 151 1454 1110 January 28th, 2016 ... This is an abstract of the original noodl. To continue reading this document, click here for the original ...
01/27/16 06:34 AMMerck Announces New Biopharma Heads for North America and China - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 January 27, 2016 Gary Zieziula to head biopharma business in... This is an abstract of the original noodl. To continue ...
01/21/16 11:06 AMMerck CEO rules out major acquisitions in 2016 - DAVOS, Switzerland--The chief executive of German pharmaceuticals giant Merck KGaA (MRK.XE) on Thursday ruled out any major mergers & acquisitions this year, saying much of the reshaping of the firm's portfolio has been completed. "We are done for the ...
01/21/16 03:05 AMMerck and BrandWatch Technologies Form Long-Term Partnership - [at noodls] - PM_BW_Merck_EN_20160121 News Release Your contact Nina Diergardt +49 6151 72-7589 January 21, 2016 Merck and BrandWatch Technologies Form Long- Term Partnership Strategic cooperation strengthens sales ...
01/20/16 03:05 AMMerck launches Vivera in Latin America - [at noodls] - 62f448ac-a3af-4e0d-aefa-c83a8c7df98f.pdf News Release Your Contact Lars Atorf +49 6151 856 3114 January 20, 2016 Merck... This is an abstract of the original noodl. To continue reading this document, click ...
01/19/16 01:05 AMMerck Appoints New Executive Board Members - [at noodls] - Press Release Template News Release Your Contact Walter Huber +49 6151 72-2287 January 19, 2016 Udit Batra and Walter... This is an abstract of the original noodl. To continue reading this document, click ...
01/17/16 05:45 PMIt's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown - It sounds confusing, but confusion is the essence of the legal battle between Germany's Merck KGaA and U.S.-based Merck & Co. ($MRK), known as MSD outside the U.S. The companies are engaged in a multicountry legal fight over the misunderstandings that come ...
01/07/16 01:08 AMMerck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing - [at noodls] - Merck_Biocartis_PR_EN News Release Your Contact Rimmi Harindran +49 6151 72-32843 January 7, 2016 Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support ...
01/04/16 07:38 AMMerck, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer - [at noodls] - SyndaxPfizerMerckCollaboration_PR_EN Your Contacts News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media: Sally Beatty +1 212 733 6566 Investor Relations: ...
01/04/16 03:08 AMUpdated Digital Version of Periodic Table of the Elements - [at noodls] - Press Release Template News Release Your Contact Neetha Mahadevan +49 6151 72-6328 January 4, 2016 Interactive periodic... This is an abstract of the original noodl. To continue reading this document, ...
12/22/15 07:10 AMMerck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab - [at noodls] - Pfizer-Merck_Alliance _Avelumab_EN_final Your Contacts News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media: Sally Beatty +1 212 733 6566 Investor ...
12/21/15 03:07 AMRonastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics - [at noodls] - PM_Pigm_21122015_E News Release Your Contact Nina Diergardt +49 6151 72-7589 December 21, 2015 Ronastar® Lapis Jewel - For Sparkling Deep Blue Cosmetics Third effect pigment in the jewel series from Merck ...
12/14/15 03:26 AMMerck Acquires Ormet Circuits - [at noodls] - PR_Ormet_10122015_EN News Release Your Contact Markus Talanow +49 6151 72-7144 Investor Relations +49 6151 72-3321 December 14, 2015 Acquisition to enhance position as semiconductor materials supplier ...
12/10/15 03:11 AMMerck Confident for 2016 - [at noodls] - 67cc9fc5-fbe0-4d8a-8c1d-687d3ea67496 News Release Your Contact Markus Talanow 06151 72-7144 Investor Relations 06151 72-3321 December 10, 2015 ... This is an abstract of the original noodl. To continue ...
12/09/15 10:09 AMMerck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers - [at noodls] - Press Release Template Your Contacts News Release Merck Media: Gangolf Schrimpf +49 6151 72-9591 Investor Relations: +49 6151 72-3321 ... This is an abstract of the original noodl. To continue reading ...
11/30/15 03:06 AMMiraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck - [at noodls] - PR_PIGM_20151130_EN News Release Your Contact Nina Diergardt +49 6151 72-7589 November 30, 2015 Miraval® Cosmic Bronze - The Second Effect Pigment in the New Product Series from Merck Intense brilliance ...
11/26/15 12:06 AMGray Modules: New Dimension in Organic Photovoltaics for Buildings - [at noodls] - Merck Performance Materials press release News Release Your Contact Judith Rahner +49 6151 72-7694 November 26, 2015 Merck´s new... This is an abstract of the original noodl. To continue reading this document, ...
11/25/15 03:15 AMMerck and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products - [at noodls] - Press Release Template Your Contacts News Release Merck Media: Gangolf Schrimpf +49 6151 72-9591 Investor Relations: +49 6151 72-3321 ... This is an abstract of the original noodl. To continue reading ...
11/20/15 01:08 AMMerck Counts on Africa for Growth - [at noodls] - c2012e5b-8cd7-4698-9878-ee214181dcdd.pdf News Release Your Contact Gangolf Schrimpf +49 151 1454 9591 November 20, 2015 ... This is an abstract of the original noodl. To continue reading this document, ...
11/19/15 07:08 AMMerck and the University of Cape Town to Develop a Drug Discovery Platform for Malaria - [at noodls] - Press Release Template News Release Your Contact Amber Chase +1-774-257-8629 November 19, 2015 Private sector and academic... This is an abstract of the original noodl. To continue reading this document, ...
11/12/15 12:06 AMMerck Reports Jump in Earnings in Q3 2015 - [at noodls] - 47589985-0cf5-43c0-a6b1-4fbbd27b002a.pdf News Release Your contact Markus Talanow +49 (0) 6151 72-7144 Investor Relations +49 (0) 6151 72-3321 November 12, 2015 ... This is an abstract of the original ...

Social

About Merck KGaA

Merck KGaA logo.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: FRA
  • Symbol: MRK
  • CUSIP:
Key Metrics:
  • Previous Close: $98.61
  • 50 Day Moving Average: $91.977
  • 200 Day Moving Average: $82.879
  • P/E Ratio: 30.154
  • P/E Growth: 1.440
  • Market Cap: $42.87B
  • Current Year EPS Consensus Estimate: $ EPS
  • Next Year EPS Consensus Estimate: $ EPS
Additional Links: